Author's reply [3]

British Journal of Radiology

Volumn 80, Issue 955, 2007, Pages 584-585

  Morcos, Sameh K ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBUTROL; GADOLINIUM CHELATE; GADOTERATE MEGLUMINE; GADOTERIDOL; IONIC CONTRAST MEDIUM; MACROCYCLIC COMPOUND; NONIONIC CONTRAST MEDIUM;

CHEMICAL REACTION; COMPLEX FORMATION; DISSOCIATION; DRUG RETENTION; HALF LIFE TIME; KIDNEY FIBROSIS; LETTER; NONHUMAN; PH; PHYSICAL CHEMISTRY; PREDICTION; REFERENCE VALUE; THERMOSTABILITY;

EID: 34548311948     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/29089802     Document Type: Letter

References (8)

1. Morcos SK. Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? Br J Radiol 2007;80:73-6.
2. Tweedle MF, Wedeking P, Kumar K. Biodistribution of radiolabeled formulated gadopentetate, gadoteridol, gadoterate and gadodiamide in mice and rats. Invest Radiol 1995;30:372-80.
3. Wedeking P, Kumar K, Tweedle MF. Dissociation of gadolinium chelates in mice: relationship to chemical characteristics. Magn Reson Imaging 1992;10:641-8.
4. Pulukkody KP, Norman TJ, Parker D, Royle L. Synthesis of charged and uncharged complexes of gadolinium and yttrium with cyclic Polyazaphosphinic acid ligands for in-vivo applications. J Chem Soc Perkin Trans 2 1993;605-20.
5. Kumar K. Macrocyclic polyamino carboxylate complexes of Gd (III) as magnetic resonance imaging contrast agents. J Alloy Compounds 1997;249:163-72.
6. Idee JM, Port M, Raynal I, Schaefer M, Greneur SL, Corot C. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 2006;20:563-76.
7. Brücher E and Sherry AD. Stability and toxicity of contrast agents. In: Merbach AE and Toth E, editors. The chemistry of contrast agents in medical magnetic resonance imaging. Chichester, UK: John Wiley & Sons, Ltd, 2001;249-57.
8. Ahmed AK, Haylor JL, El Nahas AM, Johnson TS. Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring. Kidney Int 2007;71:755-63.